These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10973461)

  • 41. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network.
    Horbar JD; Wright LL; Soll RF; Wright EC; Fanaroff AA; Korones SB; Shankaran S; Oh W; Fletcher BD; Bauer CR
    J Pediatr; 1993 Nov; 123(5):757-66. PubMed ID: 8229487
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of surfactant mixtures with reactive oxygen and nitrogen species.
    Cifuentes J; Ruiz-Oronoz J; Myles C; Nieves B; Carlo WA; Matalon S
    J Appl Physiol (1985); 1995 May; 78(5):1800-5. PubMed ID: 7649915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in immediate and short-term outcome of premature neonates treated with two types of exogenous surfactant preparation.
    Malathi I; Ng KC
    Ann Acad Med Singap; 1995 Nov; 24(6):781-4. PubMed ID: 8838980
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surface tension of therapeutic surfactants (exosurf neonatal, infasurf, and survanta) as evaluated by standard methods and criteria.
    Scarpelli EM; David E; Cordova M; Mautone AJ
    Am J Perinatol; 1992; 9(5-6):414-9. PubMed ID: 1418146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of bilirubin toxicity.
    Amato M
    Eur J Pediatr; 1995; 154(9 Suppl 4):S54-9. PubMed ID: 8529712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
    Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
    N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunosuppressive properties of surfactant and plasma on alveolar macrophages.
    Allen JN; Moore SA; Pope-Harman AL; Marsh CB; Wewers MD
    J Lab Clin Med; 1995 Mar; 125(3):356-69. PubMed ID: 7897303
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

  • 49. Platelet-activating factor in surfactant preparations.
    Moya FR; Hoffman DR; Zhao B; Johnston JM
    Lancet; 1993 Apr; 341(8849):858-60. PubMed ID: 8096563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inactivation of surfactant in rat lungs.
    Bruni R; Fan BR; David-Cu R; Taeusch HW; Walther FJ
    Pediatr Res; 1996 Feb; 39(2):236-40. PubMed ID: 8825793
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surfactant inhibits cationic liposome-mediated gene transfer.
    Tsan MF; Tsan GL; White JE
    Hum Gene Ther; 1997 May; 8(7):817-25. PubMed ID: 9143907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elastase activity and surfactant protein concentration in tracheal aspirates from neonates receiving synthetic surfactant.
    Gerdes J; Whitsett J; Long W
    J Pediatr; 1992 Feb; 120(2 Pt 2):S34-9. PubMed ID: 1735850
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exogenous surfactants in a piglet model of acute respiratory distress syndrome.
    Sood SL; Balaraman V; Finn KC; Britton B; Uyehara CF; Easa D
    Am J Respir Crit Care Med; 1996 Feb; 153(2):820-8. PubMed ID: 8564138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
    Sanghvi KP; Merchant RH
    Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
    [No Abstract]   [Full Text] [Related]  

  • 55. Lung gas volumes and expiratory time constant in immature newborn rabbits treated with natural or synthetic surfactant or detergents.
    Bongrani S; Fornasier M; Papotti M; Razzetti R; Robertson B
    Biol Neonate; 1994; 65(6):406-15. PubMed ID: 8043702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the changes in the a/A oxygen ratio after administration of two surfactants for the treatment of neonatal respiratory distress syndrome.
    Bassiouny MR; Remo C; Cherian E
    J Trop Pediatr; 1997 Feb; 43(1):38-41. PubMed ID: 9078827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group.
    Herting E; Gefeller O; Land M; van Sonderen L; Harms K; Robertson B
    Pediatrics; 2000 Nov; 106(5):957-64; discussion 1135. PubMed ID: 11061760
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cerebral blood flow velocity after surfactant instillation in preterm infants].
    Latini G
    Pediatr Med Chir; 1991; 13(4):439-40. PubMed ID: 1754482
    [No Abstract]   [Full Text] [Related]  

  • 59. Perinatal pharmacology and cerebral blood flow.
    Saliba E; Autret E; Nasr C; Suc AL; Laugier J
    Biol Neonate; 1992; 62(4):252-7. PubMed ID: 1420623
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.